What are the effects of smoking on rhinoplasty outcomes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Effects of Smoking on Rhinoplasty Outcomes

Active smoking does not appear to be a strict contraindication for rhinoplasty, as multiple recent studies demonstrate no significant differences in revision rates, infection rates, or functional outcomes between smokers and nonsmokers. However, smoking cessation should still be strongly recommended for 4 weeks preoperatively when feasible to minimize any potential complications 1, 2.

Evidence-Based Recommendation

The most recent and highest-quality evidence from 2025 shows that among 1,884 rhinoplasty patients, active smokers had similar revision rates (3.8% vs 3.3%) and infection rates compared to nonsmokers 3. While 3.8% of smokers required additional antibiotics for cellulitis versus 1.6% of nonsmokers, all cases resolved without long-term complications 3.

Key Findings Across Multiple Studies:

Complication Rates:

  • No significant differences in overall complication rates between smokers and nonsmokers in rhinoplasty specifically 3, 4, 5
  • A 2024 meta-analysis found rhinoplasty was one of only two aesthetic procedures where smoking did NOT confer statistically significant increased risk 6
  • Biochemically verified tobacco use (via serum cotinine) showed no postoperative wound complications in cotinine-positive patients 7

Functional Outcomes:

  • NOSE (Nasal Obstruction Symptom Evaluation) scores improved significantly after surgery in all smoking categories with no difference between groups 4, 5, 7
  • Change in NOSE scores: -44.0 in cotinine-positive vs -45.3 in cotinine-negative patients (p=0.70) 7

Revision Rates:

  • No statistical difference in revision requirements across smoking categories 3, 4, 5

Important Caveats and Nuances

When Smoking Does Matter:

While rhinoplasty appears relatively protected, smoking significantly increases complications when polydioxanone (PDS) plates are used for septal reconstruction:

  • Current smokers showed 3.65-fold increased early complications (statistically significant) 8
  • 4.20-fold increase in late complications (large effect but not statistically significant) 8

The Nasal Vascular Supply Advantage:

The robust vascular supply of the nasal region likely mitigates smoking's typical detrimental effects on tissue perfusion and wound healing that are seen in other body regions 3. This explains why rhinoplasty differs from procedures like abdominoplasty and breast reduction where smoking clearly increases complications 6.

Guideline-Based Preoperative Approach

Per cardiac surgery ERAS guidelines (applicable to all elective surgery):

  • Screen all patients for smoking using validated tools 1
  • Recommend cessation 4 weeks before elective surgery when feasible 1
  • Smoking cessation for 1 month is associated with improved postoperative outcomes 1

Per cardiovascular society guidelines:

  • Intensive smoking cessation interventions 4-8 weeks before surgery reduce postoperative complications 2
  • However, smoking cessation can be implemented at any time without increasing complication risk 2
  • Those who quit >4 weeks before surgery experience significantly lower respiratory and wound-healing complications 2

Clinical Algorithm

For elective rhinoplasty patients who smoke:

  1. Counsel on smoking cessation - recommend 4 weeks preoperatively if time permits
  2. Do NOT delay or deny surgery if patient continues smoking (unless using PDS plates for reconstruction)
  3. Proceed with surgery using standard perioperative optimization
  4. Monitor slightly more closely for cellulitis (though risk remains low at 3.8%)
  5. Provide standard postoperative antibiotics as per protocol

Special consideration: If planning septal reconstruction with PDS plates, strongly emphasize smoking cessation or consider alternative materials given the 3.65-fold increased early complication risk 8.

Common Pitfalls to Avoid

  • Don't refuse rhinoplasty solely based on smoking status - the evidence doesn't support this restriction 3, 5
  • Don't assume patient-reported smoking status is accurate - serum cotinine testing may be considered if concerned, though outcomes appear similar regardless 7
  • Don't expect compliance with nasal irrigation or topical antimicrobials to significantly alter outcomes - a 2025 study found no difference in ROE scores based on compliance with these interventions 9

References

3
Research

Evaluating the Safety of Rhinoplasty in Smokers.

Plastic and reconstructive surgery, 2025

5
Research

Nasoseptal Surgery Outcomes in Smokers and Nonsmokers.

Facial plastic surgery & aesthetic medicine, 2021

7
Research

Evaluating Outcomes in Septorhinoplasty Procedures Using Serum Cotinine as a Measure for Tobacco Use.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Related Questions

Can pseudoephedrine be given after rhinoplasty?
What are the risks and benefits of using L‑methylfolate as an adjunct treatment for attention‑deficit/hyperactivity disorder (ADHD)?
Does L‑methylfolate provide any benefit as an adjunct treatment for attention‑deficit/hyperactivity disorder (ADHD)?
What is the recommended protocol for flushing a central venous catheter with heparinised saline?
With an alanine aminotransferase of 53 U/L and a gamma‑glutamyl transferase of 59 U/L, can valproic acid be initiated?
What is the recommended lamotrigine dosing regimen and monitoring plan for augmenting treatment in adults with obsessive‑compulsive disorder who have had an inadequate response to a full trial of a selective serotonin reuptake inhibitor and cognitive‑behavioral therapy?
How much total fluid should be administered to a patient with diabetic ketoacidosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.